Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-amilofruse 10mg/80mg/5ml oral liquid
0202040B0AAAIAI
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilofruse 2.5mg/20mg/5ml oral liquid
0202040B0AAAJAJ
|
Co-amilofruse | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Co-amilozide 5mg/50mg/5ml oral solution
0202040C0AAACAC
|
Co-amilozide | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Co-Betaloc SA tablets
0204000W0BBABAB
|
Co-Betaloc | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Co-Betaloc tablets
0204000W0BBAAAA
|
Co-Betaloc | Metoprolol tartrate with diuretic | Cardiovascular System | No data available |
|
Co-dergocrine mesilate 1.5mg tablets
0206040AMAAAAAA
|
Co-dergocrine mesilate | Co-dergocrine mesilate | Cardiovascular System | No data available |
|
Co-dergocrine mesilate 4.5mg tablets
0206040AMAAABAB
|
Co-dergocrine mesilate | Co-dergocrine mesilate | Cardiovascular System | No data available |
|
Co-prenozide 160mg/0.25mg modified-release tablets
0204000Y0AAAAAA
|
Co-prenozide | Co-prenozide (Oxprenolol hydrochloride/cyclopenthiazide) | Cardiovascular System | No data available |
|
Co-tenidone 100mg/25mg/5ml oral liquid
020400040AAACAC
|
Co-tenidone | Co-tenidone (Atenolol/chlortalidone) | Cardiovascular System | No data available |
|
Co-zidocapt 12.5mg/25mg tablets
0205051G0AAABAB
|
Co-zidocapt | Co-zidocapt (Hydrochlorothiazide/captopril) | Cardiovascular System | No data available |
|
CoaguChek PT testing strips
0208020W0BBAAA0
|
CoaguChek (Reagent) | INR blood testing reagents | Cardiovascular System | No data available |
|
Colestid 1g tablets
0212000K0BBACAC
|
Colestid | Colestipol hydrochloride | Cardiovascular System | No data available |
|
Colestid 5g granules sachets (Imported (Canada))
0212000K0BBADAA
|
Colestid | Colestipol hydrochloride | Cardiovascular System | No data available |
|
Colestyramine 500mg/5ml oral liquid
0212000F0AAAGAG
|
Colestyramine (Lipid lowering) | Colestyramine | Cardiovascular System | No data available |
|
Colixil XL 4mg tablets
0205040D0BFAAAQ
|
Colixil | Doxazosin mesilate | Cardiovascular System | No data available |
|
Congescor 1.25mg tablets (Teva)
0204000H0BKACAM
|
Congescor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Congescor 1.25mg tablets (Tillomed)
0204000H0BKAAAM
|
Congescor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Congescor 2.5mg tablets (Teva)
0204000H0BKADAJ
|
Congescor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Congescor 2.5mg tablets (Tillomed)
0204000H0BKABAJ
|
Congescor | Bisoprolol fumarate | Cardiovascular System | No data available |
|
Cordarone X 150mg/3ml solution for injection ampoules
0203020D0BBACAD
|
Cordarone X | Amiodarone hydrochloride | Cardiovascular System | No data available |
|
Cordilox 120mg tablets
0206020T0BCACAF
|
Cordilox | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Cordilox 160mg tablets
0206020T0BCADAG
|
Cordilox | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Cordilox 40mg tablets
0206020T0BCAAAC
|
Cordilox | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Cordilox 80mg tablets
0206020T0BCABAD
|
Cordilox | Verapamil hydrochloride | Cardiovascular System | No data available |
|
Cordilox MR 240mg tablets
0206020T0BCAFAH
|
Cordilox | Verapamil hydrochloride | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.